Metraipolis › archive › dc_d36680f0545d

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway — Europe PMC PMID:42091854

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42091854
DOI
10.1038/s41419-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-02T17:42:05.538Z
SHA-256 of the archived text
2a07472952d3a94559565d96bec985a3cba2cecb0280f5cb03eab057fdfaf262
Stable URL of this page
https://metraipolis.com/documento/dc_d36680f0545d

How to cite

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway — Europe PMC PMID:42091854 — Europe PMC (en), https://europepmc.org/article/MED/42091854 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d36680f0545d (Metraipolis archive dc_d36680f0545d, sha256 2a07472952d3a94559565d96bec985a3cba2cecb0280f5cb03eab057fdfaf262)
BibTeX
@misc{dcd36680f0545d,
  title = {mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway — Europe PMC PMID:42091854},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42091854},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d36680f0545d; sha256 2a07472952d3a94559565d96bec985a3cba2cecb0280f5cb03eab057fdfaf262},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42091854. Agents can read the archived copy with the MCP tool read_document.